TXG- 10x Genomics, Inc.

Name: 10x Genomics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

10x Genomics, Inc. (TXG) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 50 sells. TXG is classified in the Health Care Technology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Saxonov Serge	1.07M	$22.58M	-
Other	Hindson Benjamin J.	432.6K	$9.11M	-
Dir	Stuelpnagel John R	359.6K	$7.58M	-
CFO	Taich Adam	297.4K	$6.27M	-
Dir	Mateo Alan	77.0K	$1.62M	-

Activity

Buys and sells only

Transactions

10 filings · page 9

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jan 3, 2022	Hindson Benjamin J.82	See Remarks	Sale+OE	41,666	$146.08	$6,086,404.05	-3.9%	-43.5%	-75.8%
Dec 30, 2021	Stuelpnagel John R89	Director	Sell	5,000	$150.92	$754,589.62	-0.7%	-50.5%	-75.8%
Dec 30, 2021	Kosaraju Sridhar90	Director	Sell	1,500	$150.38	$225,568.95	-33.3%	-50.5%	-75.8%
Dec 13, 2021	Crutchfield Bradford87	Chief Commercial Officer	Sale+OE	17,000	$139.36	$2,369,096.38	-5.5%	-60.0%	-74.7%
Dec 7, 2021	Saxonov Serge80	Chief Executive Officer	Sale+OE	15,000	$145.97	$2,189,523.82	-0.2%	-53.4%	-76.7%
Dec 1, 2021	Stuelpnagel John R89	Director	Sell	5,000	$151.16	$755,819.93	-0.3%	-43.9%	-72.6%
Dec 1, 2021	McAnear Justin J.84	Chief Financial Officer	Sale+OE	10,000	$147.75	$1,477,481.06	-2.4%	-43.9%	-72.6%
Dec 1, 2021	Hindson Benjamin J.82	See Remarks	Sale+OE	41,666	$148.08	$6,169,697.22	-6.8%	-43.9%	-72.6%
Nov 24, 2021	Kosaraju Sridhar90	Director	Sell	1,500	$150.06	$225,084.45	-25.0%	-47.9%	-76.3%
Nov 22, 2021	McAnear Justin J.84	Chief Financial Officer	Sell	281	$148.38	$41,695.09	-0.7%	-46.8%	-76.2%

← PrevPage 9Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC